City of Hope | Strategic Alliance Partners
Latest from City of Hope
Dr Kaiser on Advances With Minimally Invasive Surgery in CRC
April 01, 2025
Video
Andreas M. Kaiser, MD, discusses the benefits of minimally invasive surgery for patients with colorectal cancer.
Ethical Considerations in the Conduct of Clinical Cancer Research Always a Timely Topic
March 28, 2025
Article
The evolution of biomedical research continues to pose quite thorny ethical dilemmas.
City of Hope-Led Study Demystifies Tumor Formation’s Two-Step Process — A Foundational Understanding Needed to Prevent Cancer
March 27, 2025
Article
Preclinical data showed that mutated cells can persist for years without becoming cancer and require additional inflammatory push for malignancy to occur.
Targeted Treatment and Improved Radiation Technologies Offer Advantages in CRC Realm
March 25, 2025
Article
Yufei Liu, MD, PhD, discusses current radiation strategies, including SBRT and IMRT, along with the benefits of radiation therapy in colorectal cancer.
Five Under 5: Top Oncology Videos for the Week of 3/16
March 23, 2025
Article
The top 5 OncLive videos of the week cover insights in gynecologic cancer, multiple myeloma, urothelial cancer, MPNs, and prostate cancer.
Dr Bryce on the Comparative Efficacy of ARPIs Regardless of Disease Volume or Timing of Metastases in mHSPC
March 21, 2025
Video
Alan H. Bryce, MD, discusses treatment comparisons of ARPI efficacy according to disease volume and timing of metastasis development in mHSPC.
Dr Liu on SBRT and IMRT in Colorectal Cancer
March 20, 2025
Video
Yufei Liu, MD, PhD, discusses SBRT and IMRT strategies and the role of radiation in patients with colorectal cancer.
Ponatinib Monotherapy Maintains MRD Negativity Following TKI/Chemotherapy Treatment in Ph+ ALL: With Ibrahim T. Aldoss, MD; and Elias Jabbour, MD
March 20, 2025
Podcast
Drs Aldoss and Jabbour discuss an analysis of PhALLCON that support the use of ponatinib monotherapy after TKI/chemotherapy treatment in Ph-positive ALL.
Comprehensive Communication Regarding CRC Surgery and Postoperative Complications Is Crucial
March 20, 2025
Article
Andreas M. Kaiser, MD, discusses strategies to reduce postoperative complications and determine surgical eligibility in patients with CRC.
CA19-9 Plus Liquid Biopsy Represents Diagnostic Biomarker of Interest for Early-Stage Pancreatic Cancer Detection
March 19, 2025
Article
Ajay Goel, PhD, AGAF, discusses the potential utility of CA19-9 with an exosome-based liquid biopsy as a diagnostic biomarker in early-stage pancreatic cancer.
Minimally Invasive Surgical Approaches Are a Convenient and Effective CRC Management Option
March 18, 2025
Article
Andreas M. Kaiser, MD, discusses the differences between minimally invasive surgical approaches for colorectal cancer in community vs academic settings.
Dr Phillips on Future Avenues for Improving the Management of High-Risk MCL
March 13, 2025
Video
Tycel J. Phillips, MD, MPH, discusses the need for more large, randomized clinical trials enrolling patients with high-risk MCL.
Dr Lee on the Rationale for Using Integrative Medicine in Patients With GI Cancers
March 04, 2025
Video
Richard T. Lee, MD, discusses research showing the benefits of acupuncture, ginger, and ginseng for improving symptoms in patients with GI cancers.
Dr Li on the Casdozokitug/Atezolizumab/Bevacizumab in Unresectable HCC
February 28, 2025
Video
Daneng Li, MD, discusses a trial evaluating casdozokitug plus atezolizumab and bevacizumab in unresectable, locally advanced or metastatic HCC.
Dr Ebrahimi on Clinical Outcomes With the Addition of CBM588 to Cabozantinib and Nivolumab in RCC
February 27, 2025
Video
Hedyeh Ebrahimi, MD, MPH, discusses clinical outcomes with CBM588 plus cabozantinib and nivolumab in metastatic renal cell carcinoma.
Clinical Trials, Randomized Data Are Key to Further Refine Treatment Selection in Advanced Non–Clear Cell RCC
February 27, 2025
Article
Charles B. Nguyen, MD, provides insight into current challenges faced in the non–clear cell RCC landscape beyond the NCCN’s recent guideline updates.
Orca-Q Delivers Early Evidence of GVHD Risk Mitigation in Hematologic Malignancies
February 26, 2025
Article
Amandeep Salhotra, MD, discusses data that have demonstrated the anti-GVHD activity of post-transplant Orca-Q in patients with hematologic malignancies.
Experts Break Down Practice-Informing Presentations From the 2025 Genitourinary Cancers Symposium
February 19, 2025
Article
Experts across the field of GU oncology share important insights and spotlight key research presented at the 2025 GU Cancers Symposium.
Dr Phillips on the Rationale of Evaluating Glofitamab in R/R Mantle Cell Lymphoma
January 17, 2025
Video
Tycel Phillips, MD, MPH, discusses the rationale of the phase 1/2 NP30179 trial evaluating glofitamab in relapsed/refractory mantle cell lymphoma.
Dr LeVee on Immune-Related AEs Associated With ICIs in Early Breast Cancer
January 06, 2025
Video
Alexis LeVee, MD, discusses immune-related adverse effects in patients with early breast cancer treated with immune checkpoint inhibitors.